Nabila Chowdhury, MS
Nabila Chowdhury accomplished her BSc and MS degree from the Department of Biochemistry and Molecular Biology, University of Chittagong, Bangladesh, and started her research carrier in June 2012 at Laboratory of Eukaryotic Gene Expression and Function, BMB, CU. At EuGEF she participated in number of projects. Primarily, she focused on understanding the pattern of TLR expression in arsenic exposed human to explore the mechanism of inflammation and immune alteration during arsenicosis; later on, involved to understand the signaling molecules in cancer progression under the supervision of Dr. ASM Noman to identify novel diagnostic, prognostic and therapeutic approaches for cancer patients. Now, she is working at EuGEF Lab to address novel mutational maps of the master regulators in cancer pathogenesis under the supervision of Drs. ASM Noman, MM Hossain, and S Chowdhury.
In addition, she is interested in watching short films, movies based on biography and travelling new places. She loves to spend her time to study life to uncover its secrets and to find ways to solve problems through research. She loves enjoying her weekends with family specially with her children.
Noman AS, Parag RR, Rashid MI, Islam S, Rahman MZ, Chowdhury AA, Sultana A, Jerin C, Siddiqua A, Rahman L, Nayeem J, Chowdhury N, et al.. Chemotherapeutic resistance of head and neck squamous cell carcinoma is mediated by EpCAM induction driven by IL-6/p62 associated Nrf2-antioxidant pathway activation. Cell death & disease. 2020 Aug 20;11(8):1-5.
Noman AS, Parag RR, Rashid MI, Rahman MZ, Chowdhury AA, Sultana A, Jerin C, Siddiqua A, Rahman L, Shirin A, Nayeem J, Chowdhury N, et al.. Widespread expression of Sonic hedgehog (Shh) and Nrf2 in patients treated with cisplatin predicts outcome in resected tumors and are potential therapeutic targets for HPV-negative head and neck cancer. Therapeutic advances in medical oncology. 2020 Mar;12:1758835920911229.